190 related articles for article (PubMed ID: 26511813)
21. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of in vitro efficacy of docetaxel-loaded calcium carbonate aragonite nanoparticles (DTX-CaCO
Hammadi NI; Abba Y; Hezmee MNM; Razak ISA; Kura AU; Zakaria ZAB
In Vitro Cell Dev Biol Anim; 2017 Dec; 53(10):896-907. PubMed ID: 28916966
[TBL] [Abstract][Full Text] [Related]
23. Filamin A (FLNA) modulates chemosensitivity to docetaxel in triple-negative breast cancer through the MAPK/ERK pathway.
Zhao P; Ma W; Hu Z; Zang L; Tian Z; Zhang K
Tumour Biol; 2016 Apr; 37(4):5107-15. PubMed ID: 26546439
[TBL] [Abstract][Full Text] [Related]
24. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
25. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
[TBL] [Abstract][Full Text] [Related]
26. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
27. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells.
Zhao G; Li Y; Wang T
Biochem Biophys Res Commun; 2017 May; 487(2):255-261. PubMed ID: 28412359
[TBL] [Abstract][Full Text] [Related]
29. Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma.
Wang R; Huang J; Feng B; De W; Chen L
Mol Med; 2012 Jul; 18(1):874-86. PubMed ID: 22460125
[TBL] [Abstract][Full Text] [Related]
30. Nimotuzumab increases chemosensitivity of human lung adenocarcinoma cell lines to docetaxel.
Song HZ; Yi J; Chen J; Chen LB
Oncol Res; 2012; 20(1):39-47. PubMed ID: 23035364
[TBL] [Abstract][Full Text] [Related]
31. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
32. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
[TBL] [Abstract][Full Text] [Related]
33. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
34. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M
Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156
[TBL] [Abstract][Full Text] [Related]
35. [Effects of poly(ADP-ribose)polymerase inhibitor AG014699 combined with chemotherapy on the proliferation of triple-negative breast cancer cell line MDA-MB-231].
Sun Y; Ding H; Li XQ; Li L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Apr; 36(2):135-9. PubMed ID: 24791791
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
[TBL] [Abstract][Full Text] [Related]
38. Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms.
Gong X; Smith JR; Swanson HM; Rubin LP
Molecules; 2018 Apr; 23(4):. PubMed ID: 29662002
[TBL] [Abstract][Full Text] [Related]
39. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
Almawash SA; Mondal G; Mahato RI
Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]